Puma Biotechnology (PBYI) Inventory (2017 - 2026)
Puma Biotechnology's (PBYI) quarterly Inventory came in at $8.7 million in Q1 2026, down 0.66% YoY from $8.8 million in Q1 2025, and up 57.62% on a QoQ basis from $5.5 million in Q4 2025.
Puma Biotechnology (PBYI) Inventory (2017 - 2026) Analysis & Trends
Puma Biotechnology (PBYI) has 10 years of Inventory data on file, last reported at $8.7 million in Q1 2026.
- Quarterly Inventory fell 0.66% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (down 0.66% YoY) and the FY2025 annual result came in at $5.5 million, down 36.78% from the prior year.
- Inventory advanced to $8.7 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $9.5 million in Q3 2025 to a low of $2.7 million in Q3 2024.
- A 5-year average of $6.9 million and a median of $7.1 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2024 — Inventory sank 52.93% — and 2025, when it surged 254.51%.
- Tracing PBYI's Inventory over 5 years: stood at $4.5 million in 2022, then soared by 56.43% to $7.1 million in 2023, then advanced by 23.22% to $8.7 million in 2024, then slumped by 36.78% to $5.5 million in 2025, then soared by 57.62% to $8.7 million in 2026.
- The last three Inventory figures came in at $8.7 million (Q1 2026), $5.5 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Puma Biotechnology | 451.24 Mn | 357.33 Mn | 44.03 Mn | 13.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.32 Mn |
| Mar 31, 2026 | 8.69 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 9.48 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Mar 31, 2025 | 8.75 Mn |
| Dec 31, 2024 | 8.72 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Sep 30, 2023 | 5.68 Mn |
| Jun 30, 2023 | 7.63 Mn |
| Mar 31, 2023 | 3.89 Mn |
| Dec 31, 2022 | 4.53 Mn |
| Sep 30, 2022 | 5.45 Mn |
| Jun 30, 2022 | 6.67 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 7.11 Mn |
| Sep 30, 2021 | 7.21 Mn |